EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 13 March 2025

News

EFPIA response to the Critical Medicines Act
11 March 2025

EFPIA supports the European Commission’s ambition to strengthen Europe’s medicines supply chain through the Critical... Read more

EFPIA begins legal proceedings in European court, to seek clarity on Urban Wastewater Treatment...
10 March 2025

EFPIA believes that the obligations that the Directive imposes on producers of medicines run counter to key principles... Read more

EU-X-CT: The Recommendations Public Consultation period is extended until 31st March

The public consultation for the EU-X-CT draft recommendations has been extended, giving you more time to share your feedback.

If you haven’t had the chance to review the recommendations, now is the time. Your insights are essential to ensuring these guidelines support safe and equitable access to cross-border clinical trials in Europe.

Review the draft and submit your comments here.

Learn more here.

Videos

Watch the webinar recording of "The case for investing in a healthier future for the EU"

In a time of slow economic growth, geopolitical instability, and increasing pressures on healthcare systems, strategic... Read more

Discover MEP Stine Bosse's priorities for a healthier, more competitive Europe

In this short interview, MEP Stine Bosse discusses how we can make Europe healthier in the next EU mandate by ensuring... Read more

Events

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
03 April 2025 (Virtual event)

Register now to join this webinar. Read more

International conference on protein stability – The gap between industry and administration...
13 May 2025 (Södertälje Science Park, Sweden)

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial... Read more

Inspection landscape: Good Manufacturing and Distribution Practices (GMP/GDP)

Have a look at the new EFPIA leaflet "Inspection Landscape: Good Manufacturing and Distribution Practices". It outlines the main challenges and recommends approaches to streamline and enhance inspections, such as reliance pathways.

What we are reading

Preparing for the next pandemic with the CARE project
On 11 March 2025 (IHI)

After the outbreak of the COVID-19 pandemic in 2020, several projects including the CARE consortium were funded by... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu